Training in the pharmacology of abused drugs
滥用药物药理学培训
基本信息
- 批准号:10407551
- 负责人:
- 金额:$ 76.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1976
- 资助国家:美国
- 起止时间:1976-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
During the current funding period, this program has continued its outstanding record of educating scholars
as independent investigators and leaders in drug-abuse research. Since the submission of our last
competitive application in 2015, competition for support from this program has been robust, and all slots
have been filled. Twenty-five pre-doctoral and 14 post-doctoral trainees have received support from the
grant, these trainees have published 149 papers, and 10 pre-doctoral and 5 post-doctoral trainees have
earned individual NIH fellowships. Looking forward, we are poised to continue this record of success. We
have recruited 2 new drug-abuse faculty in pharmacology as well as 5 new faculty members with relevant
skills and interests from other departments. Moreover, recognizing the many strengths of the Department
of Pharmacology and Toxicology, the dean has authorized the recruitment of up to 10 additional well-
established faculty to join our team of 22 drug-abuse faculty. Additionally, a large increase in the number
of clinical faculty in recent years justifies our request to increase the number of both pre and post-doctoral
trainees by 2. Further support for this requested increase comes from the fact that there are more than 90
research grants from NIDA at this institution, and this is the only institutional training grant. Our preceptors
provide trainees with “cutting edge” expertise in molecular, cellular, behavioral, clinical, and translational
research. The program continues to emphasize pharmacology, but it has truly developed into a university-
wide program open to trainees from all schools and incorporating multiple disciplines. The broad academic
scope of the program is accomplished through rigorous core courses and a wide variety of advanced
electives, a high level of collaboration among mentors to include reciprocal service on thesis committees,
and multiple excellent seminar series. Additional initiatives are proposed to increase the diversity of the
trainees and enhance mentor training. These academic opportunities complement a research
infrastructure supported by a NIDA P30 grant that provides for the development of genetically altered
animals, sophisticated bioanalytical technology, and expertise in advanced gastrointestinal and
neuropharmacology research methodologies. Academic and research training is further supplemented by
guidance on teaching, professional development for a career in drug-abuse science, and all aspects of
becoming a productive, independent researcher. Our goal is to build on the program’s established record
of success by continuing to provide a rigorous and supportive atmosphere for training leading scholars in
the drug-abuse field for the future.
项目摘要
在当前的资助期间,该计划继续对学者进行杰出的记录
作为药物滥用研究的独立研究者和领导者。自从我们上次提交以来
2015年的竞争应用程序,该计划的支持竞争非常强大,所有位置
已经填满了。二十五十五十五名和14名博士后学员已获得
这些受训者的格兰特(Grant)发表了149篇论文,10名博士后和5名博士后学员有
获得了个人NIH奖学金。展望未来,我们被毒死了,继续这一成功记录。我们
已经招募了2位药理学的新毒品教师以及5名新教师
来自其他部门的技能和兴趣。此外,认识到部门的许多优势
院长的药理学和毒理学,已授权招募多达10个额外的好处
成立的教职员工加入我们的22名毒品滥用教师的团队。此外,数字大幅增加
近年来,临床教师证明了我们要求增加前后数量的要求
受训者以2。对这一要求的进一步支持,从90多个事实中增加了
NIDA在该机构的研究赠款,这是唯一的机构培训补助金。我们的受体
为学员提供分子,细胞,行为,临床和翻译方面的“最前沿”专业知识
研究。该计划继续强调药理学,但它已经真正发展成为一所大学 -
广泛的计划向所有学校的学员开放,并融合了多个学科。广泛的学术
该计划的范围是通过严格的核心课程和各种高级的范围来完成的
选修课,导师之间的高度合作,包括在论文委员会上提供相互服务,
和多个出色的半身系列。提出了其他举措来增加
学员和增强培训。这些学术机会补充了一项研究
NIDA P30赠款支持的基础设施,该赠款提供了普遍更改的发展
动物,精致的生物分析技术以及晚期胃肠道和专业知识
神经药理学研究方法。学术和研究培训进一步补充
教学指南,药物滥用科学职业的专业发展以及所有方面
成为一名富有成效的独立研究人员。我们的目标是建立该计划的既定记录
通过继续为培训领先的学者提供严格而支持的氛围,从而取得成功
未来的毒品滥用领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William L. Dewey其他文献
Derivatives of Apomorphine and of Other <em>N</em>-Substituted Norapomorphines
- DOI:
10.1002/jps.2600651129 - 发表时间:
1976-11-01 - 期刊:
- 影响因子:
- 作者:
Edward R. Atkinson;S.P. Battista;Istvan E. Ary;Donald G. Richardson;Louis S. Harris;William L. Dewey - 通讯作者:
William L. Dewey
Excretion of <em>trans</em>-Δ<sup>9</sup>-Tetrahydrocannabinol and Its Metabolites in Intact and Bile Duct-Cannulated Rats
- DOI:
10.1002/jps.2600620506 - 发表时间:
1973-05-01 - 期刊:
- 影响因子:
- 作者:
Robert F. Turk;Louis S. Harris;William L. Dewey - 通讯作者:
William L. Dewey
Mo1598 - Colonic Supernatants from Chronic Morphine Exposed Mice Induce Morphine Tolerance in Naïve Dorsal Root Ganglion Neurons that is Mitigated by Oral Vancomycin Delivery
- DOI:
10.1016/s0016-5085(17)32537-4 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Ryan Mischel;William L. Dewey;Hamid I. Akbarali - 通讯作者:
Hamid I. Akbarali
Preparation and Activity of <em>β</em>-Substituted Acetylcholine Iodides
- DOI:
10.1002/jps.2600601144 - 发表时间:
1971-11-01 - 期刊:
- 影响因子:
- 作者:
George H. Cocolas;Ellen C. Robinson;William L. Dewey;Theodore C. Spaulding - 通讯作者:
Theodore C. Spaulding
Mo1539 - μ-Opioid Receptors Co-Expressed in Cholinergic Neurons of Mouse Ileum Myenteric Plexus Develop Tolerance to Chronic Morphine Exposure
- DOI:
10.1016/s0016-5085(17)32478-2 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Karan Muchhala;Aravind Gade;William L. Dewey;Hamid I. Akbarali - 通讯作者:
Hamid I. Akbarali
William L. Dewey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William L. Dewey', 18)}}的其他基金
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
- 批准号:
10604263 - 财政年份:2013
- 资助金额:
$ 76.45万 - 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
- 批准号:
9189703 - 财政年份:2013
- 资助金额:
$ 76.45万 - 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
- 批准号:
10374821 - 财政年份:2013
- 资助金额:
$ 76.45万 - 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
- 批准号:
8552155 - 财政年份:2013
- 资助金额:
$ 76.45万 - 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受中的作用
- 批准号:
7278267 - 财政年份:2006
- 资助金额:
$ 76.45万 - 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受中的作用
- 批准号:
7465564 - 财政年份:2006
- 资助金额:
$ 76.45万 - 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受性中的作用
- 批准号:
7148489 - 财政年份:2006
- 资助金额:
$ 76.45万 - 项目类别:
相似国自然基金
CD40hiCD138hiPIR-Ahi巨噬细胞训练免疫的形成及其促进慢性排斥反应的机制研究
- 批准号:82371794
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
面向底层视觉任务的通用自监督预训练基础模型研究
- 批准号:62371164
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
认知原理启发的训练仿真系统战场空间表示方法研究
- 批准号:62306329
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支持深度伪造检测的精细化高效训练集生成方法研究
- 批准号:62372423
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
面向大规模图预训练模型的知识迁移关键问题研究
- 批准号:62376129
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Impact of Cocaine History on Pharmacotherapy Effectiveness
可卡因史对药物治疗效果的影响
- 批准号:
10750162 - 财政年份:2023
- 资助金额:
$ 76.45万 - 项目类别:
Locus coeruleus-norepinephrine regulation of stress-induced anxiety and opioid reinstatement
蓝斑-去甲肾上腺素对应激性焦虑和阿片类药物恢复的调节
- 批准号:
10677132 - 财政年份:2023
- 资助金额:
$ 76.45万 - 项目类别:
Elucidating the role of the endogenous opioid dynorphin in reward seeking
阐明内源性阿片类强啡肽在寻求奖励中的作用
- 批准号:
10722734 - 财政年份:2023
- 资助金额:
$ 76.45万 - 项目类别:
Molecular target and circuitry underlying the preclinical effects of psychedelics in models of opioid use disorder
阿片类药物使用障碍模型中迷幻药临床前作用的分子靶点和电路
- 批准号:
10751173 - 财政年份:2023
- 资助金额:
$ 76.45万 - 项目类别:
The University of Kentucky Racial Equity Initiative Coordinating Center
肯塔基大学种族平等倡议协调中心
- 批准号:
10740150 - 财政年份:2023
- 资助金额:
$ 76.45万 - 项目类别: